Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present IRIDEX Corp. (NASDAQ: IRIX).

Full DD Report for IRIX

You must become a subscriber to view this report.


Recent News from (NASDAQ: IRIX)

IRIDEX Announces FDA Clearance to Introduce Updated TruFocus LIO Premiere(TM) Laser Accessory to the U.S. Market
MOUNTAIN VIEW, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of its updated TruFocus LIO Premiere™ laser accessory following U.S. Food and Drug Administration (FDA) 510(k) review and clearance.   The TruFocus...
Source: GlobeNewswire
Date: September, 06 2018 16:05
IRIDEX Cyclo G6(TM) Laser System for Glaucoma Treatment Used in Majority of Top U.S. Ophthalmology Hospitals
MOUNTAIN VIEW, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ), a leading provider of innovative laser systems in ophthalmology, is pleased to announce that the Company’s Cyclo G6 Glaucoma Laser System is used in 35 of the 39 “Best Hospitals for...
Source: GlobeNewswire
Date: August, 30 2018 08:00
IRIDEX Corporation (IRIX) CEO William Moore on Q2 2018 Results - Earnings Call Transcript
IRIDEX Corporation (IRIX) Q2 2018 Earnings Conference Call August 02, 2018 05:00 PM ET Executives Leigh Salvo - Head of Investor Relations William Moore - Chairman, President and Chief Executive Officer Atabak Mokari - Chief Financial Officer and Vice President of Corporate Devel...
Source: SeekingAlpha
Date: August, 05 2018 11:35
IRIDEX beats by $0.04, beats on revenue
IRIDEX (NASDAQ: IRIX ): Q2 EPS of -$0.28 beats by $0.04 . More news on: IRIDEX Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 02 2018 16:17
IRIDEX Announces 2018 Second Quarter Results and Raises Full Year 2018 Guidance
MOUNTAIN VIEW, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended June 30, 2018. Second Quarter Highlights Cyclo G6™ product revenue increased approximately 58% year-over-ye...
Source: GlobeNewswire
Date: August, 02 2018 16:05
IRIDEX to Report Second Quarter 2018 Financial Results on August 2, 2018
MOUNTAIN VIEW, Calif., July 19, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter 2018 after the close of trading on Thursday, August 2, 2018.  The Company’s management team will host a co...
Source: GlobeNewswire
Date: July, 19 2018 16:05
IRIDEX Reaches Milestone of 1000th Cyclo G6 System Shipped
MOUNTAIN VIEW, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced that in the second quarter of 2018 it has shipped the 1,000th unit of its Cyclo G6™ Laser System, which utilizes the Company’s proprietary MicroPulse® technology for ...
Source: GlobeNewswire
Date: July, 10 2018 08:00
IRIDEX Announces Approval of CYCLO G6(TM) Glaucoma Laser System in Korea
MOUNTAIN VIEW, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the approval of its CYCLO G6™ Glaucoma Laser system by South Korea's Ministry of Food and Drug Safety (MFDS).  Currently available in more than 50 countries, the CYCLO G6 tr...
Source: GlobeNewswire
Date: June, 19 2018 08:00
IRIDEX's (IRIX) CEO Will Moore on Q1 2018 Results - Earnings Call Transcript
IRIDEX Corporation (IRIX) Q1 2018 Earnings Conference Call May 3, 2018 17:00 ET Executives Leigh Salvo - Investor Relations Will Moore - Chief Executive Officer Atabak Mokari - Chief Financial Officer Analysts David Solomon - ROTH Capital Partners Larry Haimovitch - HMTC ...
Source: SeekingAlpha
Date: May, 07 2018 11:25
IRIDEX beats by $0.02, beats on revenue
IRIDEX (NASDAQ: IRIX ): Q1 EPS of -$0.31 beats by $0.02 . More news on: IRIDEX Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 03 2018 16:19

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-089.248.55259.248.559,272
2018-05-176.8357.187.206.7611,506
2018-02-266.006.166.955.3101207,575
2018-02-237.337.417.647.0012,748
2018-02-227.457.207.457.11114,344

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-146,61512,62352.4043Short
2018-12-1390010,6848.4238Cover
2018-12-127,06234,60620.4069Cover
2018-12-113,85125,41015.1555Cover
2018-12-1010013,9870.7149Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IRIX.


About IRIDEX Corp. (NASDAQ: IRIX)

Logo for IRIDEX Corp. (NASDAQ: IRIX)

Not available

 

Contact Information

 

 

Current Management

  • Barry G. Caldwell / President, CEO
  • Meryl A. Rains / CFO

Current Share Structure

  • Market Cap: $82,322,806 - 05/11/2018
  • Issue and Outstanding: 11,627,515 - 03/01/2018

 


Recent Filings from (NASDAQ: IRIX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 27 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 16 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018

 

 


Daily Technical Chart for (NASDAQ: IRIX)

Daily Technical Chart for (NASDAQ: IRIX)


Stay tuned for daily updates and more on (NASDAQ: IRIX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: IRIX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IRIX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IRIX and does not buy, sell, or trade any shares of IRIX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/